Neurofeedback as a Treatment for Trauma-affected Refugees
- Conditions
- Post Traumatic Stress Disorder
- Registration Number
- NCT05055037
- Lead Sponsor
- Mental Health Services in the Capital Region, Denmark
- Brief Summary
Neurofeedback (NF) is a form of treatment that can assist individuals in learning to control their brain wave activity. NF-studies have shown promising results in reducing PSTD-symptoms among military veterans, but there are no published peer-reviewed studies with refugees. However, preliminary studies from Malmö and Sydney indicate that refugees could benefit from NF. Therefore, at the Competence Centre for Transcultural Psychiatry (CTP) a longitudinal feasibility study, testing NF for trauma-affected was started. The study contains both a quantitative and a qualitative substudy. In in the quantitative substudy, where a total of 32 participants have been included, the aim was to evaluate the feasibility of NF with trauma affected refugees using a quantitative perspective. The NF intervention offered was 12 training sessions of 12-20 minutes NF, and the outcome measures were self-administered questionnaires and semi-structured interviews collected before and after the intervention. In a subsample of eight participants of those included in the quantitative substudy, qualitative in-depth interviews were carried out. The participants were offered two interviews; one before the first NF training and one during the treatment course. The aim of the qualitative substudy was to evaluate the feasibility of NF with trauma-affected refugees by examining the participants' thoughts and expectations prior to participating in NF treatment as well as their experience with the treatment after a few sessions.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- Refugee or a person who had been family reunified with a refugee
- Diagnosed with PTSD (ICD-10 diagnosis F43.1) and experienced a psychological trauma in another country than Denmark.
- Informed consent.
- Current abuse of drug or alcohol (F1x.24-F1x.26)
- Diagnosed with a severe psychotic disorder (F2x) or a manic disorder (F30.1-F31.9).
- No informed consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Harvard Trauma Questionnaire (HTQ) Baseline and after 12 weeks Change in PTSD symptoms measured by the first 16 items in the Harvard Trauma Questionnaire
- Secondary Outcome Measures
Name Time Method Satisfaction and Accept-ability Questionnaire (SAQ) After 12 weeks Evaluation of the the patients' satisfaction and potential discomfort.
WHO-Five Well-being Index (WHO-5) Baseline and after 12 weeks Change in quality of life
Hamilton interview-based rating scales for depression (Ham-D) and anxiety (Ham-A) Baseline and after 12 weeks Change in depressive and anxiety symptoms
Hopkins Symptom Checklist-25 (HSCL-25) Baseline and after 12 weeks Change in depressive and anxiety symptoms
Sheehan Disability Scale (SDS) Baseline and after 12 weeks Changes in functioning
Trial Locations
- Locations (1)
Competence Centre for Transcultural Psychiatry
🇩🇰Ballerup, Denmark